Summary
Corneal confocal microscopy (CCM) is an imaging method to quantify neurodegeneration and regeneration. It is timely to start the conversation on how to translate evidence into action and provide a roadmap to assess the current evidence and key hurdles for the adoption of CCM as a biomarker and surrogate endpoint for neurodegenerative disease.